Status:

TERMINATED

Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma

Lead Sponsor:

New York State Psychiatric Institute

Conditions:

Glioblastoma

Eligibility:

All Genders

21-70 years

Phase:

PHASE1

Brief Summary

The goal of this single arm Phase I feasibility study is to investigate the tolerability of cannabis with concurrent chemoradiation in the treatment of glioblastoma multiforme (GBM). A strain of canna...

Detailed Description

The purpose of this study is to determine the feasibility and the effects of cannabis with high concentrations of CBD in patients receiving chemoradiation for GBM. This is not a therapeutic study for ...

Eligibility Criteria

Inclusion

  • Diagnosis of Glioblastoma requiring standard care chemoradiation of concurrent Temozolomide and 60 Gy of radiation given over 30 treatments
  • Age 21-70
  • Able to give informed consent, and comply with study procedures

Exclusion

  • Meet DSM-V criteria for current major psychiatric illness, such as bipolar disorder, major depression, active suicidal intent, or psychosis that could be exacerbated by the administration of cannabis
  • Meet DSM-V criteria for major neurological disorder, such as mild cognitive impairment or neurodegenerative disorders (such as movement disorders, dementia), that could be exacerbated by the administration of cannabis.
  • Women who are not practicing an effective form of birth control (condoms, diaphragm, birth control pill, IUD) or currently pregnant.
  • Current (weekly) use of cannabis.
  • Patients on supplemental oxygen or history of chronic obstructive pulmonary disease (COPD).
  • Cardiovascular Disease
  • Compromised Immunity
  • Patients with a history of substance use disorder other than nicotine, such an opiate use disorder.

Key Trial Info

Start Date :

March 19 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 9 2019

Estimated Enrollment :

1 Patients enrolled

Trial Details

Trial ID

NCT03246113

Start Date

March 19 2018

End Date

May 9 2019

Last Update

August 13 2019

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Columbia University Medical Center- Department of Radiation Oncology

New York, New York, United States, 10032

2

New York State Psychiatric Institute

New York, New York, United States, 10032